Atlas Trials

Antengene Corporation

6 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Antengene Corporation

RecordFirmDate
A Study of ATG-010 in Combination With Lenalidomide and Rituximab (R2) in Adults With DLBCL and iNHL (NCT05265975)Antengene Corporation2022-04-07
A Study of ATG-010 in Combination With ATG-008 in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma (NCT05354362)Antengene Corporation2022-03-02
A Study of Evaluating the Safety and Efficacy of ATG-010, Bortezomib, and Dexamethasone (SVd) Versus Bortezomib and Dexamethasone (Vd) in Patients With Relapsed or Refractory Multiple Myeloma (RRMM) (NCT04939142)Antengene Corporation2021-07-12
A Study of Evaluating the Safety and Efficacy of ATG-010 Combined With Chemotherapy Sequential With ATG-010 Monotherapy Maintenance in Peripheral T- and NK/T-cell Lymphoma (NCT04425070)Antengene Corporation2020-08-18
A Study of Evaluating the Safety and Efficacy of ATG-010 in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (NCT03992339)Antengene Corporation2020-04-09
A Study of Evaluating the Safety and Efficacy of ATG-010 in Relapsed Refractory Multiple Myeloma (NCT03944057)Antengene Corporation2019-09-02

Track Antengene Corporation automatically

Every clearance here is in the API, with alerts when new ones post.